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Abstract
Carbon nanotubes (CNT) have been developed into new materials with a variety of industrial and 
commercial applications. In contrast, the physicochemical properties of CNT at the nanoscale 
render them the potency to generate toxic effects. Indeed, the potential health impacts of CNT 
have drawn a great deal of attention in recent years, owing to their identified toxicological and 
pathological consequences including cytotoxicity, inflammation, fibrosis, genotoxicity, 
tumorigenesis, and immunotoxicity. Understanding the mechanisms by which CNT induce 
toxicity and pathology is thus urgently needed for accurate risk assessment of CNT exposure in 
humans, and for safe and responsible development and commercialization of nanotechnology. 
Here, we summarize and discuss recent advances in this area with a focus on the molecular 
interactions between CNT and mammalian systems, and the signaling pathways important for the 
development of CNT toxicity such as the NF-κB, NLRP3 inflammasome, TGF-β1, MAPK, and 
p53 signaling cascades. With the current mechanistic evidence summarized in this review, we 
expect to provide new insights into CNT toxicology at the molecular level and offer new clues to 
the prevention of health effects resulting from CNT exposure. Moreover, we disclose questions 
and issues that remain in this rapidly advancing field of nanotoxicology, which would facilitate 
ascertaining future research directions.
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Introduction
The development of nanotechnology has led to the creation of a vast array of nanomaterials 
in the recent few decades. The engineered nanomaterials have at least one dimension of less 
than 100 nm, but vary in size, shape, chemical composition, and surface characteristics 
considerably, giving rise to distinct and unique physicochemical and conducting properties 
highly desirable for industrial and commercial applications. As such, nanotechnology and 
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nanomaterials are poised to revolutionize numerous fields (IWGN, 1999; NSF, 2011). 
However, the rapid increase in the production and use of nanomaterials may lead to greater 
exposure of workers, consumers, and the environment, which, alongside the uncertainty of 
the biological effects of nanoexposure, has raised considerable concerns over their potential 
effects on human health (Council, 2012; NIOSH, 2013b).
The large number and many variations of nanomaterials produced and their properties at the 
nanoscale have made it difficult, if not all impossible, to examine the entire nanomaterials 
through conventional toxicological characterizations, making risk assessment of 
nanoexposure a formidable task in the field of nanotoxicology. Therefore, it is imperative 
for toxicologists not to test every variation of a new nanomaterial, but to elucidate the mode 
of action from representative nanomaterials, such as identification of key factors and 
pathways that govern the interactions between nanomaterials and biological systems and 
their pathological consequences. Such information could then be used to predict toxicity, 
guide targeted screening, and allow safety to be built into the design of nanomaterials and 
their applications, with a goal to ultimately foster the safe and responsible development of 
the nanoindustry (Maynard et al., 2011; Stone & Donaldson, 2006). From this prospect, 
carbon nanotubes (CNT) with sp2 carbon bonding and excellent mechanical, electrical, 
thermal, and transport properties have been selected as a model nanomaterial to demonstrate 
the road of nanomaterials towards industry (De Volder et al., 2013; Zhang et al., 2013). 
Collateral to the rapid development of CNT nanotechnology, a large body of toxicological 
data has accumulated to characterize the potential health effects of CNT and as a result, the 
study on CNT toxicity has had a major impact on our understanding of the potential health 
effects of nanoexposure on humans over the past decade (Donaldson et al., 2010; Johnston 
et al., 2010).
CNT are made of one-atom-thick carbon walls called graphene that roll into long and hollow 
nanostructures with either a single layer (single-walled CNT, SWCNT) or concentric 
multiple layers (multi-walled CNT, MWCNT). SWCNT and MWCNT have large surface 
areas that can be modified to introduce specific functions on pristine nanofibers, further 
increasing the complexity and diversity of CNT. As a newly developed material, the current 
annual production capability of CNT has reached several thousand tons, and because of their 
outstanding tensile and electro- and thermal-conducting properties, CNT have been 
developed with a variety of applications in both industrial and consumer products, ranging 
from electronics, such as rechargeable batteries, to biomedical uses, such as medical devices 
and drug delivery (De Volder et al., 2013; Zhang et al., 2013).
The initial concern over the health impact of CNT exposure stemmed from the notion that 
most CNT are respirable fibers with a high aspect (length to width) ratio, and are presumed 
to have substantial biodurability and insolubility in biological systems, attributes known to 
cause the fibrotic and tumorigenic effects of toxic fibers such as asbestos (Donaldson et al., 
2006; Morgan & Gee, 1995). Animal testing has demonstrated that certain forms of CNT 
can cause fibrosis in the lungs of mice and rats upon pulmonary exposure, and the formation 
of mesotheliomas when injected into the peritoneal cavity of susceptible mice (Lam et al., 
2004; Muller et al., 2005; Poland et al., 2008; Porter et al., 2010; Shvedova et al., 2005). 
Exposure to CNT can occur from industrial, commercial, and environmental sources, as the 
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life cycles of CNT and their commercial products include not only their innovation and 
manufacturing but also their commercialization, consumer usage, disposal, recovery, and 
recycling (Figure 1). Owing to the above factors, the potential adverse impacts of CNT 
exposure in humans have drawn a great deal of attention, and some basic understanding on 
CNT pathology has been achieved, but detailed characterization awaits further investigation. 
Nonetheless, progress has been made in several aspects in the recent few years, which 
provides a necessary knowledge base to guide future mechanistic and translational studies 
on nanotoxicity and safety.
First and foremost, characterization of CNT toxicity in a variety of animal and in vitro 
models has revealed an increasing list of toxic effects of CNT exposure, which includes, in 
addition to the originally suspected fibrotic and mesothelioma-causing effects, a range of 
cytotoxic effects, inflammation, genotoxicity, and immune modulation. These findings have 
created a broader basis for assessing the structure–activity relationship, mechanism of 
action, and health risk of CNT toxicity. Second, analysis of the structure–activity 
relationship has uncovered a close correlation between the toxicity and the size, shape, 
composition, and surface characteristics of CNT fibers, which impact the distribution, 
clearance, internal dose, and intrinsic pathogenicity of CNT fibers. Such knowledge is 
highly desirable for improving nanosafety by the way of prevention-through-design. Third, a 
body of information has been gathered to reveal CNT’s actions at cellular, subcellular, and 
molecular levels, which provided considerable new insights into the mechanisms of CNT 
toxicity. Fourth, a number of signaling pathways have been shown to be significantly 
activated by CNT and to play important roles in the development of CNT pathologic effects, 
such as tumorigenesis, inflammation, and fibrosis. A better understanding of the pathways in 
CNT toxicity would be critical for future research on the mechanisms, biomarkers, and 
intervention of CNT toxicity.
This review is intended to display the current understanding on CNT toxicity at the 
molecular level with a focus on the mechanisms and signaling pathways that play major 
roles in determining the dynamic behavior and pathologic effects of CNT in mammalian 
systems. Implications of the findings and questions that remain to be addressed in the field 
of nanotoxicology will be discussed to facilitate the founding of future research directions. 
Although CNT toxicity may be generated from a number of routes of exposure that include 
dermal and oral exposures in addition to inhalation (Johnston et al., 2010), the health 
concerns and toxicological studies on CNT exposure have mostly involved the pulmonary 
effects of CNT fibers at the present stage. Therefore, to facilitate mechanistic understanding 
of the major toxic effects of CNT, we focused the current review on CNT pulmonary 
toxicity from respiratory exposures.
The expanding CNT toxicity
The manifestations of the pulmonary effects of inhaled particles and fibers, which typically 
include inflammation and tumorigenesis, vary considerably. Those caused by inert or 
“nuisance dusts”, i.e. carbon black (CB) and titanium dioxide (TiO2) particles, follow a 
similar dose–response curve, characteristic of poorly soluble low toxicity (PSLT) particles; 
whereas those of more chemically active materials, i.e. crystalline silica and asbestos fibers, 
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demonstrate a markedly different dose–response relationship, typical of high toxicity dusts 
(Borm et al., 2004; Maynard & Kuempel, 2005). A major accomplishment in the study of 
CNT toxicity over the past decade has been the recognition that CNT are capable of eliciting 
a wide range of biological effects in experimental systems, which exceed beyond what 
would be predicted from insoluble and “nuisance dust”-like materials, but are more similar 
to those of high toxicity dusts.
Demonstrated CNT toxicity includes various cytotoxic effects such as oxidative stress, 
mitochondrial damage, cell cycle arrest, and cell death; acute and chronic inflammation; 
interstitial fibrosis and formation of granulomas; genotoxicity with DNA and chromosomal 
aberrations; tumorigenesis such as formation of mesotheliomas in the mesothelial spaces and 
promotion of adenocarcinomas in the lungs; and modulation of immune functions such as 
immunosuppression and boosting asthmatic responses to allergens. To facilitate our 
discussion on the mechanisms of CNT action, we summarized recent findings on CNT 
toxicity in Figure 2. Detailed discussions on CNT toxicity can be found in several recent 
reviews by others (Johnston et al., 2010; Nerl et al., 2011; Zhao & Liu, 2012).
The effect of CNT on mammalian cells has been reported in multiple cell types, which 
provides guidance for screening, and mechanistic and in vivo investigations on CNT 
toxicity. CNT conferred cytotoxicity in a dose- and time-dependent manner in different cell 
types (Donaldson et al., 2006; Jia et al., 2005; Johnston et al., 2010; Pacurari et al., 2008). 
Both SWCNT and MWCNT induced secretion of inflammatory cytokines, chemokines, and 
growth factors such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, monocyte 
chemotactic protein (MCP)-1, and transforming growth factor (TGF)-β1, in mouse 
RAW264.7 macrophages (He et al., 2011, 2012; Shvedova et al., 2005), indicating that CNT 
have the potential to trigger inflammatory responses. CNT-treated cells demonstrated 
elevated levels of intracellular reactive oxygen species (ROS) in a variety of cell types, 
which leads to oxidative stress and toxicity (Alarifi et al., 2014; He et al., 2011, 2012; 
Pacurari et al., 2008). In addition, CNT generate genotoxic effects in cultured cells, such as 
DNA strand breakage, DNA base oxidation, formation of micronuclei, and chromosomal 
aberrations, which were recently reviewed by van Berlo et al. (2012). These genotoxic 
effects of CNT suggest a potential of CNT to cause cancer in animals and humans.
In vivo characterization of the responses to CNT exposure in animals has been pivotal in 
disclosing the hazardous effects of CNT. First, CNT were found to induce lung 
inflammation and fibrosis in mice and rats, as have been predicted from their size and fiber 
shape (Aiso et al., 2010; Dong et al., 2014; Lam et al., 2004; Mangum et al., 2006; Muller et 
al., 2005; Park et al., 2011; Porter et al., 2010, 2013; Reddy et al., 2012; Shvedova et al., 
2005; Wang et al., 2013; Warheit et al., 2004). The inflammatory response includes the 
accumulation of inflammatory cells and elevated secretion of cytokines, chemokines and 
growth factors in the lungs and the bronchoalveolar lavage (BAL) fluid, and formation of 
epithelioid granulomas in the lung parenchyma. The fibrogenic response was evaluated by 
histopathological analysis of lung tissues, such as increased fibrous collagen level and 
thickened alveolar wall. In addition, inflammation and fibrosis were observed in the pleural 
space and the abdominal cavity upon direct injection into the spaces (Murphy et al., 2011; 
Poland et al., 2008; Ryman-Rasmussen et al., 2009a). Second, from the genotoxicity of CNT 
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identified in cultured cells (discussed above) and in different strains of mice (Kato et al., 
2013; Patlolla et al., 2010; Shvedova et al., 2008a), carcinogenesis has been linked to CNT-
induced pathologic effects. Mesotheliomas were observed in mice and rats after exposure to 
MWCNT through intraperitoneal or intrascrotal injection (Nagai et al., 2011; Sakamoto et 
al., 2009; Takagi et al., 2012). Recently, it was reported that inhalation of MWCNT at a 
dose relevant to human occupational exposures, following administration of a tumor initiator 
methylcholanthrene (MCA), induced a high incidence of lung adenocarcinomas in mice, 
demonstrating MWCNT is a potent tumor promoter in the lungs (Sargent et al., 2014). 
Third, CNT modulate immune functions both systemically and locally. Inhalation of 
MWCNT caused systemic immunosup-pression in mice characterized by reduced T-cell-
dependent antibody to sheep erythrocytes, reduced T-cell proliferation in the presence of 
Concanavalin A, and decreased NK (natural killer) cell activity (Mitchell et al., 2007). 
Inhalation of MWCNT also exacerbated airway remodeling in a murine allergic asthma 
model pre-challenged with ovalbumin (OVA), revealing a potential of CNT to increase 
asthmatic responses (Inoue et al., 2009; Ryman-Rasmussen et al., 2009b). In addition, CNT 
have been shown to modulate the expression of multiple cytokines and other factors critical 
in immune functions such as Th2 (T helper 2) cytokines and IgE (immunoglobulin E) (Park 
et al., 2009; Yamaguchi et al., 2012).
Although the spectrum of CNT toxicity has expanded substantially, many of the observed 
biological effects of CNT are scalable and thus, are predictable from those of non-
nanoscaled materials. Nonetheless, it has been postulated that some CNT fibers, because of 
their similarity in size and shape to certain structures in the cell, such as the spindle 
microtubules, may replace or perturb the function of the cellular structures to result in harm 
to the cell, for instance, disrupt the mitotic spindle during mitosis to lead to clastogenic 
effects (Muller et al., 2008; Sargent et al., 2012). However, further evidence from molecular, 
cellular, and animal studies are needed to substantiate this hypothesis. Therefore, whether 
and how the unique properties of CNT at the nanoscale, which defines nanotechnology, can 
be applied to the propensity of the materials to cause harm in biological systems remain a 
major challenge for future study.
Another major challenge in the study of CNT toxicity derives from the fact that the 
manufactured nanomaterials differ considerably in their structures and physicochemical 
properties, making it very difficult, if not impossible, to compare among different forms of 
CNT, for instance, between SWCNT and MWCNT, despite all CNT use graphene as the 
building block and have a fiber-like shape. Even with the same CNT product, minor 
variations among different batches of manufacturing may alter their behaviors and 
toxicological endpoints in biological systems considerably, underscoring the importance of 
identifying CNT properties critical for their toxicity in nanosafety evaluation.
Factors affecting the intrinsic pathogenicity and internal dose of CNT
Considerable information has been gathered to disclose the physicochemical properties and 
in vivo kinetic behaviors of CNT that determine the intrinsic pathogenicity and internal dose 
of the nanomaterials, inasmuch as such knowledge would facilitate predicting the health 
risks of CNT and designing safer nanomaterials.
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On one hand, pristine CNT are insoluble in biological fluids. Moreover, CNT are generally 
considered highly biopersistent, i.e. having a long half-life, in biological systems compared 
with most other carbonaceous substances for several reasons. First, CNT are resistant to 
biological degradation mechanisms, because their building block, graphene, is an 
exceedingly strong material made of strong sp2, instead of the more common sp3, carbon–
carbon bonds. Second, CNT fibers with a large aspect ratio, for instance, a length of >10 µm, 
are more difficult to be cleared off from the lungs and plural space by macrophages and 
through size-dependent mechanisms, such as the stomatal openings, as discussed in more 
detail below. Third, CNT also tend to form large bundles and aggregates in tissues making 
them more difficult to be removed from their site of deposition.
On the other hand, a recent study indicated that SWCNT may be susceptible to 
myeloperoxidase (MPO)-catalyzed and reactive radical-dependent degradation in vitro in 
neutrophils and, to a lesser extent, in macrophages. In this scenario, the basic amino acids of 
MPO interact with the carboxyl groups of SWCNT to position the nanotubes near the 
enzyme’s catalytic site. Hypochlorite and the reactive radical intermediate of MPO carry out 
the degradation (Kagan et al., 2010). Consistent with these findings, MPO knockout mice 
were shown to have impaired clearance and enhanced pulmonary inflammatory and fibrotic 
responses to SWCNT in the lungs (Shvedova et al., 2012a). Whether MPO catalyzes the 
degradation of more sophisticated CNT including MWCNT effectively remains to be 
examined. Nonetheless, the findings provide new insights into CNT biodegradation and 
biopersistence, and suggest potential new ways of reducing the pathogenicity of 
carbonaceous nanomaterials including CNT in the body via MPO.
As a result of the CNT’s insolubility and biopersistence, CNT toxicity, typified by 
pulmonary inflammation and fibrosis, resembles a response to foreign body deposition, 
wherein the deposition of CNT in alveoli and small airways causes local damage and 
triggers acute inflammation characterized by marked infiltration of inflammatory cells. The 
alveolar and interstitial macrophages engulf deposited CNT to facilitate their clearance via 
the mucociliary clearance system of the airway or to the circulation via local lymphatic 
vessels. As discussed above, fibrogenic CNT are resistant to these mechanisms of clearance, 
leading to their continued presence and accumulation in the lungs and consequently, chronic 
inflammation, interstitial fibrosis, and granuloma formation (Mercer et al., 2011).
Rigidity and physical state
MWCNT and SWCNT differ in their rigidity and physical state, which affect the dispersion, 
distribution, and pathogenicity of the fibers.
Long and straight (i.e. needle-like) MWCNT fibers with lengths of 5–20 µm, but not short, 
entangled MWCNT (1–5 µm), were shown to exhibit asbestos-like behavior and induced 
mesothelial granulomatous inflammation upon injection into mouse peritoneal cavity 
(Poland et al., 2008). Long, needle-like CNT and asbestos, but not CB, short CNT, or long 
and tangled CNT, stimulated the secretion of IL-1β from macrophages, indicating activation 
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of the inflammasome pathway responsible for the maturation and secretion of IL-1β 
(Palomaki et al., 2011).
In recent studies, MWCNT and SWCNT were compared: the MWCNT tested are fiber-like 
with a mean diameter of 49 nm and a mean length of 3.9 µm; whereas the SWCNT are 
thread filament-like with a mean diameter of 1–4 nm and a length of several hundred nm. 
Thus, the MWCNT are more rigid and straighter than the SWCNT. The MWCNT appeared 
to be more easily dispersed than the SWCNT in solution; and importantly, the MWCNT 
showed a greater tendency to penetrate cells and membranous structures, and to reach distal 
spaces and organs from the port of entry in vivo, including the pleural space of the thorax 
and extra-pulmonary organs such as the kidneys and liver. These findings raised the 
possibility of extra-pulmonary effects from inhalation of CNT (Mercer et al., 2011, 2013b).
CNT may aggregate to form agglomerates in the form of ropes (fiber-like), loose bundles, or 
large agglomerate mass (particlelike). Aggregation of CNT fibers would change the overall 
surface area available for interaction with target cells and molecules and thereby, affect 
CNT biological effects. Compared with singlet or small bundles of CNT, large agglomerates 
of CNT are more difficult to be cleared off and thus, tend to stimulate the formation of 
granulomas in which macrophages are transformed to epithelioid cells to segregate CNT 
from the surrounding tissues. CNT agglomerates may also release singlet CNT fibers over 
time, resulting in the redistribution and alteration of the internal dose of CNT in different 
compartments and organ systems in the body, causing extended and potentially, unexpected 
effects in extrapulmonary organs (Mercer et al., 2013a).
In one study, four SWCNT preparations from the same CNT source (raw CNT, CNT 
agglomerates, well-dispersed CNT bundles, and pellet from centrifugation of the CNT 
bundles that contains non-tube shaped carbonaceous particulate matters) were compared. 
The CNT raw material and agglomerates, but not CNT bundles, were found to inhibit the 
proliferation of a mesothelioma cell line, supporting the notion that the physical states of 
CNT affect toxicity (Wick et al., 2007). In another study, treatment with acetone was used to 
reduce Van der Waals attractions among CNT fibers to result in a better “dispersed” 
preparation. Acetone treatment reduced the diameters of SWCNT aggregates from ~15.2 µm 
to ~0.69 µm. The untreated SWCNT were shown to be easily encased by macrophages to 
form granulomas, whereas the acetone-treated SWCNT induced an interstitial fibrotic 
response without apparent granuloma formation. These findings suggest that agglomeration 
of CNT promotes macrophage engulfment of CNT fibers to induce granulomatous 
inflammation (Mercer et al., 2008).
In the comparison between SWCNT and MWCNT discussed above, the SWCNT were 
mostly present within the interstitial space (up to 90% of the lung burden) with few being 
incorporated into alveolar macrophages upon inhalation into the lungs; but the MWCNT 
were predominantly distributed within the alveolar and interstitial macrophages (68% of the 
lung burden). The differential distribution patterns of MWCNT and SWCNT in the lungs 
appeared to correlate with their ability to induce the formation of granulomas (Mercer et al., 
2011). What accounts for the differential distribution of the SWCNT and MWCNT fibers is 
currently unclear. Presumably, the properties of SWCNT and MWCNT, such as rigidity and 
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physical state, as well as surface area and fiber length, affect their interactions with 
macrophages and the microenvironment to result in preferential distributions in different 
compartments in the lungs.
Fiber length
Fibrogenic and tumorigenic fibers with a high aspect ratio, such as asbestos and CNT, differ 
from particles in that the inhaled fibers may reach the pleural space and cause parietal 
pleural lesions leading to pleural fibrosis, effusion, and mesotheliomas, in addition to 
causing interstitial fibrosis and tumors in the lungs. In the case of asbestos, the capacity of 
the pathogenic fibers to induce both lung and pleural lesions is directly correlated with the 
length of the fibers, which was summarized in the so-called “fiber pathogenicity paradigm”, 
that is, to be hazardous, a fiber must be biopersistent and thinner than 3 mm, but longer than 
10–20 µm (Adamson et al., 1993; Davis et al., 1986; Stanton, 1973). The regulated forms of 
“asbestos”, as defined by World Health Organization (WHO), Occupational Safety and 
Health Administration (OSHA), and National Institute for Occupational Safety and Health 
(NIOSH), denote asbestos fibers with a length longer than 5 µm and an aspect ratio of 3:1–
5:1, which was largely based on the fiber length–pathogenicity relationship of pathogenic 
fibers (Case et al., 2011, Liu et al., 2013).
A fiber length–toxicity relationship was demonstrated for CNT recently by comparing the 
pathologic effects of CNT fibers with different lengths injected into the peritoneal or pleural 
cavity. In these scenarios, long, but not short, CNT fibers (i.e. >15 µm in length) induced 
significant inflammatory and fibrotic responses and granuloma formation on the parietal 
mesothelium (Murphy et al., 2011; Poland et al., 2008), as well as mesotheliomas in the case 
of peritoneal injection in p53+/− mice (Takagi et al., 2008). By using single-photon 
emission computed tomographic imaging, it was shown that the long, but not short, CNT 
fibers were retained along the parietal mesothelium. Presumably, on one hand, short CNT 
fibers were cleared off quickly from the cavities through the stomatal openings (3–10 µm in 
diameter) on the surface of the parietal pleural wall and the diaphragm, which drain into 
local lymphatic vessels. On the other hand, long CNT fibers could not negotiate through the 
stomata leading to their accumulation on the parietal surface. Retained CNT would then be 
engulfed by macrophages, which are 10–15 µm in diameter; but long CNT could not be 
effectively phagocytized, resulting in “frustrated phagocytosis” that damages the 
mesothelium and stimulates inflammation, which ultimately lead to chronic inflammation, 
fibrosis, and malignancy (Donaldson et al., 2010). These findings imply that the parietal 
pleural mesothelium is the site of initial pathological alterations, thus providing a rationale 
for estimating the internal dose of pathogenic CNT for pleural lesions at the parietal pleural 
surface. Because mesothelioma has a long latency and is generally difficult to study with 
regard to its course of tumorigenesis and development, the pleural findings at the stomata 
also provide an opportunity for analyzing the early events that would lead to mesothelioma.
It remains to be examined whether and how this fiber length– pathogenicity relationship 
demonstrated for CNT pleural toxicity are applied to the fibrotic and tumorigenic effects of 
CNT in the lungs, because the lung parenchyma does not seem to have a “sieve” mechanism 
similar to the stomata of the pleural parietal mesothelium for selective retention of CNT 
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fibers in the lungs. Nonetheless, such a relationship is predicted for CNT by analogy with 
the findings on asbestos’ effects in the lungs, i.e. asbestosis and lung cancer, and on the 
basis of a critical role of macrophages in the clearance of CNT fibers from the lungs, both of 
which are fiber length-dependent. This notion was supported by two recent studies. First, 
long MWCNT (NM400, 0.7–3 µm and NM402, 0.7–4 µm) as well as crocidolite asbestos, 
but not short MWCNT (MWCNTg2400, 0.7 µm) and crushed NM400 (NM400c, 0.14–0.5 
mm), were shown to stimulate fibroblast proliferation in vitro and induce fibrosis in the 
lungs (Vietti et al., 2013). Second, spontaneously hypertensive (SH) rats administered with 
long MWCNT (20–50 µm), but not short MWCNT (0.5–2 mm), were found to exhibit 
increased fibroblast proliferation, collagen deposition, granuloma formation in the lungs in a 
TGF-β-depend-ent manner (Wang et al., 2013).
Surface area
The intrinsic pathogenic activity of CNT is closely correlated with their surface area, as is 
true for most other insoluble particulate matters. For this reason, surface area, as well as 
biopersistence and fiber length (discussed above) and surface reactivity (discussed below), 
are considered key elements of the “biologically effective dose” of CNT fibers.
A correlation between surface area and toxicity was clearly observed by comparing between 
SWCNT and MWCNT. When the target site dose was used to assess the fibrotic potential of 
CNT in the lungs, SWCNT were estimated to be approximately 8.5-fold more fibrogenic 
than MWCNT per µg dose. Presumably, on one hand, SWCNT fibers are lighter and have a 
larger surface area than MWCNT and thus, are more pathogenic on an equal weight basis. 
On the other hand, when adjusted for surface area, MWCNT is 2.5-time more toxic than 
SWCNT (Mercer et al., 2008, 2011; Porter et al., 2010; Shvedova et al., 2008a). Using the 
above data, a recent NIOSH Current Intelligence Bulletin suggests a benchmark dose of 
CNT exposure associated with a 10% increase in abnormal response to be 3.6 and 0.48 µg/
lung for MWCNT and SWCNT, respectively, or an approximately 7.5-fold difference 
(NIOSH, 2013a).
It is noteworthy to point out that, for safety evaluation and risk assessment of CNT toxicity, 
multiple dose metrics, including surface area, mass concentration, and fiber number, should 
be used where possible, even though there is a growing evidence supporting a better 
correlation between toxicity and surface area compared with other metrics (Seaton et al., 
2010).
Surface reactivity
Modification of the surface of CNT would alter their toxicity. On one hand, acid treatment 
would oxidize CNT to introduce hydroxyl and carboxyl groups on the surface of CNT, 
which alters the bioactivity and interaction of CNT with other molecules. Compared with 
pristine MWCNT, acid-oxidized MWCNT showed increased toxicity toward Jurkat cells 
(Bottini et al., 2006). On the other hand, nitrogen-doped MWCNT demonstrated 
significantly reduced toxicity and increased tolerance than their pure CNT counterparts in 
exposed mice (Carrero-Sanchez et al., 2006).
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Covalent modification or surfactant addition is sometimes called functionalization of CNT. 
Functionalized CNT are being increasingly used in industrial and commercial applications. 
Functionalization of CNT potentially affects their toxicity. In one study, on one hand, 
pristine MWCNT were dispersed in mouse serum or were functionalized with ammonium. 
Functionalization of the CNT promoted rapid excretion of the CNT from the body and thus, 
reduced toxicity in mice; on the other hand, the serum-coated MWCNT induced respiratory 
distress, which was associated with accumulation of CNT in pulmonary vasculature 
(Lacerda et al., 2008). In another study, lung cells were exposed to pristine or carboxylated 
MWCNT (MWCNT or MWCNT– COOH) and a panel of toxic responses were analyzed 
including cell survival, DNA damage, and cytokine expression. MWCNT– COOH were 
found to have increased cytotoxicity in bronchial cells compared with pristine MWCNT, 
whereas the pristine MWCNT showed higher toxicity toward alveolar cells than MWCNT–
COOH (Ursini et al., 2014). Recently, atomic layer deposition (ALD), a novel process to 
enhance functional properties of MWCNT, was used to coat MWCNT with a thin film of 
aluminum oxide (Al2O3). The “Al2O3”-coated MWCNT showed reduced fibrosis in mice 
compared with pristine MWCNT (Taylor et al., 2014).
These examples demonstrate that surface modification can both increase and decrease 
toxicity, depending on the particular modification taken, providing new ways of prevention-
through-design for CNT and other nanomaterials.
Composition
The chemical composition of CNT is generally not considered as a major determinant of 
toxicity compared with fiber length, surface area, and biopersistence. However, in the case 
of surface functionalization and coating (discussed above), and when the graphene structure 
is altered by elements other than carbon or substantial impurity is present, the chemical 
composition would be important in CNT toxicity, as it potentially alters the surface 
reactivity and/or the distribution and half-life of CNT in the body. Additionally, it remains 
possible that the coated materials, functionalized groups, and contaminants would be 
detached from CNT fibers upon entering the body and be released into tissues over time to 
cause harm to cells locally or systemically. However, few studies have been conducted to 
address these possibilities.
Metals present in a CNT preparation may affect the biological effects of CNT. Metals, such 
as iron and nickel, are used as catalysts during the production of CNT. The metal content of 
a CNT preparation appeared to affect some, but not all, toxicological effects of CNT. For 
instance, SWCNT with an iron content of ~26% showed a greater effect in inducing ROS 
production than the iron-depleted preparation that has an iron content of ~0.23%, in both 
cell-free systems and cultured cells (Kagan et al., 2006). In a separate study, unpurified 
SWCNT (iron content, 30%) were shown to be more cytotoxic to skin cells in vitro 
compared with acid-treated counterparts (iron content, 0.23%), and their toxicity was 
decreased with the addition of a metal chelator. The unpurified CNT also caused skin 
pathology upon topical application, compared with acid-washed CNT. These findings 
support a critical role of metals in the toxic effects of CNT (Murray et al., 2009). In contrast, 
the iron contents of a number of different CNT samples (iron contents, 0.53–26.9%) did not 
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appear to affect their potentials to induce granulomas in mice, which may be more related to 
the CNT’s tendency to aggregate and induce a foreign body response in the lungs (Lam et 
al., 2004).
Molecular mechanisms of CNT toxicity
Given the considerable progress made in understanding the structure-toxicity relationship of 
CNT, it remains an important task to elucidate how CNT interact with cellular 
macromolecules to elicit specific pathologic effects, such as inflammation, fibrosis, and 
tumorigenesis; and how the physicochemical properties of CNT affect the CNT-biological 
interactions at the molecular level, both of which remain poorly understood. In this regard, 
several molecular processes associated with toxicities of pathogenic particles and fibers 
were observed in animal and in vitro models exposed to CNT, which would allow certain 
broad conclusions to be drawn with regard to the mechanisms underlying CNT toxicity.
Oxidative stress
One of the most consistent observations that would associate CNT exposure to toxicity 
mechanistically is oxidative stress, a cellular stress state caused by an imbalance between 
the production of ROS and antioxidant defense to result in harm to the cell. Biologically 
relevant ROS include oxygen radicals ( , •OH, RO2•, and RO•) and oxygen species that 
are oxidizing agents and/ or are easily converted to radicals (H2O2, HOCl, O3, and 1O2). 
Eukaryotes are constantly exposed to ROS, resulting from both internal metabolism, such as 
the mitochondrial oxidative phosphorylation and the plasma membrane-bound NADPH 
(nicotinamide adenine dinucleotide phosphate) oxidase (NOX)-catalyzed reactions, as well 
as exogenous exposures, such as bacterial infection and exposure to particles, fibers, and 
transition metals. ROS may serve useful purposes under a physiological condition, such as 
regulation of cell proliferation and immune response, and killing of invading microbes 
during phagocytosis. However, overproduction of ROS would overwhelm the body’s 
antioxidant capacity, leading to damages to macromolecules such as DNA strand break, 
DNA mutation, protein peptide chain break, and lipid peroxidation, and eventually cell 
death. Therefore, ROS production and anti-oxidation are consequences of oxygen utilization 
in mammalian physiology, and oxidative stress contributes to the development of a range of 
diseases including aging, cancer, neurodegeneration, and chronic inflammatory pathology 
such as asbestosis and silicosis (Finkel, 2005; Ma, 2010).
Both SWCNT and MWCNT increased the production of ROS, often accompanied with 
elevated levels of oxidative markers, depletion of antioxidants, and induction of antioxidant 
enzymes in animals (Han et al., 2010; Rothen-Rutishauser et al., 2010; Shvedova et al., 
2007). CNT may stimulate ROS production via a direct effect on cells, as they induced 
oxidative stress in a number of cell types including macrophages, bronchial and alveolar 
epithelial cells, and fibroblasts in vitro (Brown et al., 2007; He et al., 2011, 2012; Rothen-
Rutishauser et al., 2010; Thurnherr et al., 2011). On one hand, deficiency of vitamin E in 
animal diet, which decreases the body’s antioxidant capacity, caused oxidative stress and 
increased the sensitivity to SWCNT-induced lung lesions in mice (Shvedova et al., 2007). 
On the other hand, addition of antioxidants or ROS scavengers alleviated oxidative stress 
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and inflammatory cytokine expression in cells exposed to MWCNT (Brown et al., 2010; 
Han et al., 2010).
In addition to directly damaging macromolecules and cellular structures to result in 
cytotoxicity and cell death (Ma, 2010), ROS can activate signaling pathways, such as the 
NF-κB (nuclear factor-κB) signaling pathway, to boost the production and secretion of 
proinflammatory and profibrotic cytokines and growth factors that promote inflammation 
and fibrosis (He et al., 2011, 2012). ROS may also serve as signaling molecules to regulate 
growth factor-induced proliferation and differentiation of fibroblasts critical in the 
fibrogenic response to CNT. ROS have been implicated in transducing the signals of 
epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) to stimulate cell 
proliferation by boosting tyrosine phosphorylation signaling through their plasma membrane 
receptors and NADPH oxidases (Dickinson & Chang, 2011; Finkel, 2011), as well as 
activating cellular programs such as the inflammasome and autophagy signaling pathways 
(Ma, 2013; Shvedova et al., 2012b). Given the long half-life of CNT fibers in the body, it 
would be expected that there is continued production of ROS and prolonged oxidative stress 
in CNT-deposited tissues over a long period of time. Therefore, strategies to suppress ROS 
production by administering antioxidants would not be sufficient to prevent or halt CNT-
induced lung fibrosis, if the tissue burden of CNT is not effectively reduced.
CNT may boost ROS production in several ways. First, in accordance with the fiber length 
paradigm, long CNT fibers (415 mm in length) can cause “frustrated phagocytosis” in which 
macrophages are activated but cannot effectively engulf the long fibers that exceed their 
body diameter. “Frustrated” macrophages release the contents of their phagosomes including 
digestive enzymes, anti-microbial agents, and highly toxic ROS and reactive nitrogen 
species (RNS), resulting in local inflammation and destruction of surrounding tissues 
(Brown et al., 2007). Second, many SWCNT and MWCNT fibers are shorter than 10 mm, 
but are capable of inducing ROS production in vitro and in vivo. In these scenarios, 
phagocytosis of CNT by activated macrophages are also necessary for induction of oxidative 
stress, and entangled or long and straight CNT generate considerably more ROS than CNT 
that are short and have a relatively small surface area (Rothen-Rutishauser et al., 2010). 
Third, in addition to being the power house and a major source of ROS production in 
mammalian cells under physiologic conditions, the mitochondria are prone to damage by 
toxic agents including pathogenic fibers to result in oxidative stress. Both SWCNT and 
MWCNT have been shown to induce mitochondrial damage and elevated ROS production 
in lung cells (He et al., 2011, 2012). Fourth, NOXs, a group of membrane enzymes, can 
generate superoxide anion and hydroxyl radicals near the plasma membrane. NOX2 
(gp91phox) is responsible for the “respiratory burst” during phagocytosis by neutrophils and 
other phagocytic cells. NOX2 was shown to play a role in the transition of CNT-induced 
acute inflammation to chronic fibrosis in mice, as the NOX2 knockout mice exposed to 
SWCNT exhibited significantly more proinflammatory, but not profibrotic, phenotypes 
compared with wild-type (Shvedova et al., 2008b). Lastly, impurities from CNT 
preparations, such as iron and other transition metals, can stimulate the Fenton (Fe2+ + H2O2 
→Fe3+ + •OH + OH−) or Fenton-like (Mnn+ + H2O2→Mn(n+1)+ + •OH + OH−) reactions to 
result in ROS production and oxidative stress in biological systems.
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In addition to ROS, exposure to particles and fibers, such as silica and asbestos, has been 
shown to stimulate the expression of inducible nitric oxide synthase (iNOS) in the lungs that 
produces nitric oxide (NO•) (Kang et al., 2000). NO• serves as a gaseous signaling molecule 
for blood vessel relaxation or as a neurotransmitter in the brain physiologically, but it may 
also react with ROS to form stronger oxidants such as the potent peroxynitrite (ONOO−). 
Overproduction of NO•, ONOO−, and their derivatives, which are collectively called 
reactive nitrogen species, causes nitrosative stress that contributes to toxicity and disease 
pathogenesis in the body (Pacher et al., 2007). RNS have been implicated in the 
development of silicosis and asbestosis, but whether CNT stimulate RNS production to 
cause nitrosative stress and toxicity remains controversial, as both positive and negative 
results for iNOS induction have been observed (Lee et al., 2012; Pulskamp et al., 2007).
Inflammation
The tissue response to CNT deposition in the lungs and in the pleural and abdominal cavities 
resembles a foreign body-induced response in that it initiates with a marked acute 
inflammatory response, followed by prolonged or chronic pathologic alterations (Dong et 
al., 2014; Mercer et al., 2011). Acute inflammation is characterized by rapid infiltration of 
neutrophils and macrophages and high titers of proinflammatory mediators, which peak at 
around 1–7 d and subside at 14 d post-exposure (Dong et al., 2014; Porter et al., 2010). The 
chronic response, marked by interstitial or pleural fibrosis and granulomas, is contingent on 
continued presence and accumulation of CNT in the tissue and is considered to reflect the 
function of inflammation to promote tissue repair (i.e. fibrosis) and clearance of CNT (i.e. 
granuloma formation). Thus, inflammation is a major component of the acute phase and, 
arguably, the chronic phase of the tissue response to CNT.
In vitro studies reveal that both MWCNT and SWCNT stimulate the production and 
secretion of inflammatory mediators such as TNF-α, IL-1β, IL-6, and IL-8, from a variety of 
cell types, including macrophages, bronchial and alveolar epithelia, kera-tinocytes, and 
fibroblasts (He et al., 2011, 2012). In vivo induction of inflammatory mediators by CNT has 
also been detected (Dong et al., 2014). It is believed that elevated levels of the inflammatory 
mediators in the local matrix and circulation would drive the recruitment and activation of 
inflammatory cells to cause the acute inflammatory infiltration at the site of CNT deposition. 
CNT are likely to activate specific signaling pathways, such as the NF-κB and the NLRP3 
(nucleotide-binding oligomerization domain-like receptor, pyrin domain-containing 3) 
inflammasome pathways, to up-regulate gene transcription and post-translational processing 
of inflammatory mediators, which will be discussed in more detail in later sections. The 
mediators and mechanisms that control the transition from acute to chronic inflammation 
and the subsequent propagation of the chronic phase response to CNT remain unclear for the 
most part. Together, these findings imply that anti-inflammation by targeting key mediators 
may be used to help in preventing or halting the pathologic processes caused by CNT. 
However, because CNT may persist and continuously stimulate inflammatory and 
pathogenic responses in the tissue, any anti-inflammation therapy would need to be 
administered in conjunction with measures that reduce the tissue load of CNT fibers to be 
effective.
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Cell proliferation has been recognized as a prominent molecular and cellular mechanism 
critical in tumorigenesis, fibrosis, and inflammation, which are major pathologic outcomes 
of CNT exposure in animals. Recent research has provided ample evidence demonstrating 
that CNT modulate the proliferation of a number of types of cells in vitro and in animals. 
Long MWCNT induced the proliferation of primary mouse lung fibroblasts and a number of 
fibroblast cell lines including human fetal lung fibroblasts (HFL-1), mouse embryonic 
fibroblasts (BALB-3T3), and mouse lung fibroblasts (MLg), in a dose-dependent manner; 
moreover, the potentials of different preparations of MWCNT to induce proliferation of the 
cells in vitro correlated with their fibrotic effects in vivo in C57BL/6 mice (Vietti et al., 
2013). The role of fibroblast proliferation in CNT-induced fibrosis is further discussed in the 
section below.
MWCNT exposure induced hyperplastic proliferative lesions of the visceral mesothelium in 
which the proliferating cell nuclear antigen levels were approximately 10-fold higher than 
vehicle control in F344 rats; furthermore, the pleural cavity lavage fluid from the dosed rats 
or conditioned culture media of macrophages treated with MWCNT increased mesothelial 
cell proliferation in vitro, further supporting the notion that stimulation of mesothelial 
proliferation by CNT potentially leads to the formation of mesotheliomas (Xu et al., 2012). 
Therefore, MWCNT clearly produce pathological effects by promoting cell proliferation in 
certain cell types.
The fibroblastic response
Fibroblasts play a major role in tissue fibrosis (Wynn, 2011). Upon exposure to CNT, 
fibroblasts increase in number and transform to myofibroblasts to secret a large number of 
matrix proteins such as collagens and fibronectin, as well as matrix modulating enzymes 
such as metalloproteinases, resulting in the deposition and processing of collagen proteins 
and, eventually, replacement of the parenchyma with collagen fibers, near CNT deposits. 
Pulmonary interstitial fibroblasts may derive from several sources during fibrosis, which 
conceivably include the following: (a) proliferation of resident fibroblasts in the lungs; (b) 
recruitment of bone marrow-derived fibrocytes from blood into the lung interstitial space; 
and (c) epithelial–mesenchymal transition (EMT) of airway and alveolar epithelial cells. 
MWCNT and SWCNT have been shown to stimulate fibroblast proliferation in vitro (Vietti 
et al., 2013; Wang et al., 2010a,b), transformation of fibroblasts into myofibroblasts (He et 
al., 2011, 2012), and induction of EMT (Chang et al., 2012, Chen et al., 2014). The role of 
fibrocyte recruitment in CNT toxicity has not been demonstrated.
Two mechanisms have been hypothesized to account for the effects of CNT on fibroblasts. 
First, CNT fibers may stimulate fibroblasts to proliferate and differentiate by mimicking 
endogenous collagen fibers or other fibrous structures to attract fibroblasts to adhere to their 
surface, leading to activation of the fibroblasts. Alternatively, CNT stimulate the secretion of 
profibrogenic mediators, such as the inflammatory cytokines TNF-α and IL-1β, and growth 
factors TGF-β1 and PDGF, which exert potent mitogenic effects on fibroblasts to promote 
the proliferation and differentiation of the cells (Dong et al., 2014). Although some in vitro 
and in vivo evidence has been obtained to support these posits, a definitive proof of either 
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mechanism to account for the fibrotic effects of CNT in the lungs in vivo has not been 
available.
Genotoxicity and tumorigenesis
MWCNT and SWCNT have been shown to damage DNA both in vitro and in vivo, though 
negative results have also been observed in studies with some CNT preparations (van Berlo 
et al., 2012). These potentially controversial reports likely reflect the heterogeneity in the 
physicochemical properties and the genotoxic potentials of the CNT fibers tested, as well as 
differences in the assay types and testing conditions of the studies. The spectrum of 
genotoxicity by CNT is similar to that known to be caused by tumorigenic fibers such as 
asbestos, including (a) single- and double-DNA strand breaks, as demonstrated by comet 
assay, formation of γH2AX foci, and activation of poly(ADP-ribose) polymerase 1; (b) 
oxidation of DNA base such as formation of 8-hydroxydeoxyguanosine (8-OHdG); (c) 
micronucleus formation; (d) clastogenic and aneugenic effects; and (e) increased mutation 
frequency in mutation-screening model systems (Schins & Knaapen, 2007). Mutagenicity 
tests in bacterial strains have been mostly negative for CNT (and asbestos in this regard). In 
light of these findings, it was proposed that CNT do not damage DNA by directly acting on 
DNA. Instead, CNT cause genetic lesions indirectly via several mechanisms. First, CNT 
may stimulate cells to produce DNA-damaging ROS as discussed above, to cause DNA base 
oxidation and DNA strand breaks. Second, CNT may suppress DNA repair and thereby 
facilitate genotoxic processes. This notion was supported by the findings that a decrease of 
the tumor suppressor p53 in mice enhanced tumorigenesis by MWCNT, and p53 is known to 
be critical in initiating DNA repair in the presence of DNA impairment. Third, CNT may 
cause damage to DNA as a consequence of elevated inflammatory response to CNT. Lastly, 
CNT may enter the nucleus and interfere with the mitotic machinery, i.e. the centrosomes 
and mitotic spindle, due to their similarities to the microtubules of the spindle, to result in 
clastogenic and aneugenic phenotypes (Sargent et al., 2010, 2012).
Tumorigenesis is a multi-step process involving an initial insult(s) to the genome, failure of 
the defense and repair mechanisms, and neoplastic growth and progression. CNT 
tumorigenicity was studied in two types of animal cancer models, i.e. induction of 
abdominal mesothelioma and promotion of lung adenocarcinoma. Intraperitoneal injection 
of MWCNT induced mesothelioma formation in heterozygous p53+/− mice at high (3 mg/
mouse) and low (30 or 300 µg/mouse) doses in two separate studies (Takagi et al., 2008, 
2012). In a study on rats, thin MWCNT (diameter approximately 50 nm) with high 
crystallinity showed inflammogenicity and mesotheliomagenicity, but thick (diameter 
approximately 150 nm) or tangled (diameter approximately 2–20 nm) MWCNT were found 
less toxic, inflammogenic, and carcinogenic. Moreover, the mesothelioma induced by 
MWCNT had homozygous deletion of Cdkn2a/2b tumor suppressor genes similarly to 
asbestos-induced mesothelioma (Nagai et al., 2011). In a separate study, MWCNT with 
short length (<1 µm) were found incapable of inducing inflammation and mesothelioma in 
the rat abdominal cavity, which is in accordance with the notion that short CNT would be 
rapidly cleared from mesothelial cavities through the parietal stomatal openings and would 
not induce frustrated phagocytosis (Donaldson et al., 2010; Muller et al., 2009). Taken 
together, these findings indicate that the ability of MWCNT to induce inflammation and 
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mesothelioma in the abdominal cavity is associated with their diameter-dependent piercing 
of the cell membrane to cause mesothelial injury as well as their resistance to clearance from 
the mesothelial surface, and is significantly enhanced by disruption of tumor suppression 
mechanisms.
The tumorigenicity of MWCNT in the lungs was investigated in a two-stage initiation/
promotion model (Sargent et al., 2014). B6C3F1 mice, with an intermediate susceptibility 
for spontaneous lung tumor formation, were exposed to a single intraperitoneal injection of 
vehicle or MCA (10 µg/g body weight, i.p.); followed, 1 week later, by inhalation of either 
filtered air (control) or MWCNT at 5 mg/m3, 5 h/d, 5 d/week for a total of 15d. This dose 
gave a lung burden of 31.2 mg/mouse, which is relevant to feasible human occupational 
exposures. Lung tumors were examined 17 months post-exposure. Exposure to MCA 
followed by MWCNT caused lung adenocarcinoma and adenoma formation in 90% of the 
mice with a mean of 2.9/mouse, compared with 23% in the filtered air controls (mean of 
0.25/mouse), 26.5% in the MWCNT-exposed (mean of 0.38/mouse), and 51.9% in the MCA 
followed by the filtered air-exposure (mean of 0.81/mouse) group. In addition, MCA plus 
MWCNT increased the incidence of serosal tumor, which is consistent with sarcomatous 
mesothelioma, by 4.5-fold, compared with MCA alone (9% versus 2%). These findings 
would not support MWCNT as an initiator or a complete carcinogen, but demonstrate that 
MWCNT inhaled at a dose relevant to human exposures is a strong tumor promoter in 
mouse lungs. The mechanism(s) by which MWCNT promote tumor progression remains to 
be elucidated. By analogy with the findings from asbestos, tumor promotion by MWCNT is 
likely to relate to MWCNT’s capacity to induce cytotoxicity, inflammation, fibrosis, cell 
proliferation, and cellular atypia in the lungs (Poland et al., 2008; Porter et al., 2010).
Modulation of immune functions
Inhalation of MWCNT caused systemic immunosuppression in mice, suggesting that the 
signals originated in the lungs were transduced to directly affect the functions of T cells in 
distal organs such as the spleen (Mitchell et al., 2007). Suppression of T cell functions was 
partially rescued by administering ibuprofen, a common anti-inflammatory drug that blocks 
the cyclooxygenase-2 (COX-2) pathway; moreover, mice deficient in COX-2 did not 
develop overt lung inflammation after inhaling MWCNT; in addition, proteins from the 
lungs of exposed mice suppressed the immune functions of spleen cells from normal mice, 
but not those from COX-2 knockout mice (Mitchell et al., 2009). From this study, it was 
posited that signals from the CNT-exposed lungs activate signals in the spleen to suppress 
the immune functions of exposed mice, which, in part, involves the COX-2 pathway. The 
role of COX-2 was also investigated in a murine asthmatic model using COX-2 knockout 
mice. MWCNT were shown to exacerbate the OVA-induced airway remodeling, which was 
associated with activation of a mixed Th1/Th2/Th17 immune response, and COX-2 
appeared to protect against the inflammation and mucous cell metaplasia, but not the fibrosis 
induced by OVA and MWCNT. The results demonstrate a role for COX-2 in the 
exacerbation of allergen-induced airway remodeling by MWCNT and suggest different 
pathways in the development of fibrotic and allergic responses, respectively (Sayers et al., 
2013).
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CNT alter the expression of multiple immune-related cytokines and factors, which 
contribute to their effects on the immune system in a tissue and organ-dependent manner. 
Intratracheal instillation of MWCNT resulted in elevated levels of proin-flammatory 
cytokines in a dose-dependent manner in the blood and BAL fluid, elevated Th2 and Th1 
cytokine levels, increased numbers of B cells in the spleen and blood, and enhanced 
production of IgE in mice; the findings suggest that MWCNT induce allergic responses in 
mice through B cell activation and production of IgE (Park et al., 2009). Intraperitoneal 
administration of MWCNT in mice led to increased mRNA expression of proinflammatory 
cytokines and chemokines (IL-1β, IL-33, TNF-α, and MCP-1), Th2 cytokines (IL-4, IL-5, 
and IL-13), and Th17 cytokine (IL-17) in peritoneal cells at early stage and increased 
mRNA expression of Th1 cytokines (IL-2 and interferon (IFN)-g) at a later stage, elevated 
numbers of inflammatory cells in the peripheral blood, and enhanced production of 
ovalbumin-specific IgM and IgG1 (Yamaguchi et al., 2012).
Signaling pathways of CNT toxicity
Many of the mechanisms for CNT toxicity discussed above would reflect, to a large extent, 
common strategies that cells use to perform physiologic functions and/or to cope with 
adverse insults. At the molecular level, these functions are carried out through specific 
cellular signaling pathways and programs. An increasing body of evidence indicates that a 
number of signaling pathways are activated by CNT and mediate the biological response to 
CNT, providing new molecular insights into the mechanism by which CNT induce toxic 
effects (Figure 3).
NF-κB
The transcription factor NF-κB plays an important role in immune and inflammatory 
responses by regulating the expression of genes that serve as inducers or effectors at 
multiple levels in the inflammatory networks in response to stimuli. NF-κB is activated by 
CNT in a variety of experimental conditions both in vivo and in vitro. As a result, NF-κB 
has become one of the most studied pathways involved in CNT biological effects.
CNT induced NF-κB activation in a number of cell lines. In human HaCaT keratinocytes, 
SWCNT stimulated NF-κB signaling in a dose-dependent manner, revealed by sequential 
events of the signaling pathway, including activation of IκB kinase a (IKKα), enhanced 
phosphorylation and degradation of the NF-κB inhibitor IκBα, accumulation of NF-κB 
subunit p65 in the nucleus, elevated binding of NF-κB p50/p65 complex to DNA, and 
increased NF-κB-dependent reporter gene expression (Manna et al., 2005). SWCNT induced 
NF-κB activation in a dose-dependent manner in human normal mesothelial and malignant 
mesothelial cells detected by enzyme-linked immunosorbent assay (ELISA) (Pacurari et al., 
2008). Both unpurified (30% iron) and partially purified (0.23% iron) SWCNT activated 
NF-κB in mouse epidermal JB6 P+ cells (Murray et al., 2009). NF-κB was activated by 
SWCNT in rat aortic endothelial cells (RAEC) (Zhiqing et al., 2010). In a recent study, 
SWCNT were shown to activate the NF-κB signaling cascade and increase the secretion of a 
panel of NF-κB-regulated proinflammatory cytokines and chemokines, including TNF-α, 
IL-1β, IL-6, IL-10, and MCP-1, in mouse RAW264.7 macrophages (He et al., 2012). 
Treating human alveolar epithelial A549 cells with MWCNT led to NF-κB activation and 
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increased IL-8 mRNA expression; moreover, induction of IL-8 expression was suppressed 
by NF-κB inhibitors N-tosyl-l-phenylalanine chloromethyl ketone (TPCK) and parthenolide 
(Ye et al., 2009). In a separate study, MWCNT were shown to activate the NF-κB signaling 
pathway and increase the secretion of a number of NF-κB-regulated proinflammatory 
cytokines and chemokines, including TNF-α, IL-1β, IL-6, IL-10, and MCP-1, in mouse 
RAW264.7 macrophages; moreover, activation of NF-κB involved degradation of IκBα, 
nuclear translocation of NF-κB subunit p65, binding of NF-κB to specific κB-binding sites, 
and elevated NF-κB-controlled reporter gene expression (He et al., 2011). In addition, 
MWCNT induced time-dependent phosphorylation of the NF-κB inhibitor IκBα, an 
essential step leading to IκBα degradation, NF-κB nuclear translocation, and nuclear 
accumulation of NF-κB in rat lung epithelial cells (Ravichandran et al., 2010).
Intratracheal instillation of SWCNT caused airway hyper-reactivity, airflow obstruction, and 
granuloma formation, as well as alveolar macrophage activation and chronic inflammatory 
responses in mouse lungs. Pathway analysis of Affymetrix microarray data from the mouse 
lungs indicated that NF-κB-related inflammatory responses and downstream signals 
affecting tissue remodeling played an important role to account for the SWCNT-induced 
effects (Chou et al., 2008; Hsieh et al., 2012). Treatment of mice with NF-κB inhibitor 
pyrrolidine dithiocarbamate (PDTC) attenuated the pathologic phenotypes and induction of 
inflammatory genes by SWCNT significantly, further supporting an important role of NF-
κB in the toxicity of SWCNT in vivo (Hsieh et al., 2012).
Given the complexity of the NF-κB pathway and the marked activation and involvement of 
NF-κB in CNT-induced cytotoxicity and pathology, it remains critical to elucidate the 
complicated layers of molecular mechanisms through which CNT affect NF-κB activity. In 
particular, how CNT activate the signaling pathway of NF-κB remains largely elusive. In 
this respect, several upstream signaling molecules leading to activation of NF-κB in 
response to physiologic and microbial cues have been identified, including tumor necrosis 
factor receptor (TNFR), interleukin-1 receptor (IL1R), toll-like receptors (TLRs), and 
growth factor receptors (GFRs), which may guide future studies of the interactions between 
CNT and the NF-κB pathway in the development of inflammation, fibrosis, and 
tumorigenesis by CNT.
Inflammasomes
CNT induced high levels of secreted IL-1β in culture media of macrophages treated with 
CNT (He et al. 2011, 2012; Shvedova et al., 2005) and in the BAL lavage fluid from CNT-
exposed mouse lungs (Han et al., 2010; Sager et al., 2014; Shvedova et al., 2005). Secretion 
of IL-1β requires the proteolytic processing of the protein by the NLRP3 inflammasome 
(Lamkanfi & Dixit, 2014). Since the first report on the topic by Palomaki et al. (2011), 
activation of the NLRP3 inflammasome under CNT stimulation has drawn a large attention.
Inflammasomes are cytoplasmic sensors that detect extracellular and intracellular signals 
and initiate innate immune responses in response to microbe infection and tissue injury. 
Assembled as a large complex from multiple proteins, a number of inflammasomes have 
been identified, including the NLRP1b, NLRP3, NLRC4 (nucleotide-binding 
oligomerization domain-like receptor, caspase activation and recruitment domain-containing 
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4), and AIM2 (absent in melanoma 2) inflammasomes, which have distinct protein 
compositions and are activated by distinct and specific danger signals, such as microbial 
pathogens and stress cues (Lamkanfi & Dixit, 2014; Schroder & Tschopp, 2010). The 
NLRP3 inflammasome is the most extensively studied complex, as it is implicated in 
responses to a wide range of signals derived from pathogens, endogenous danger signals, 
and environmental stimuli. This inflammasome contains the NLR (nucleotide-binding 
oligomerization domain-like receptor) protein NLRP3, the adaptor protein ASC (apoptosis-
associated specklike protein containing a caspase activation and recruitment domain), and 
the effector proteolytic enzyme caspase-1, i.e. procaspase-1. In resting cells, NLRP3 is auto-
repressed in the cytoplasm. Upon stimulation, NLRP3 is activated and oligomerized, 
followed by recruitment of ASC and procaspase-1 to form the NLRP3 inflammasome. The 
inflammasome cleaves pro-caspase-1 to become active caspase-1, which in turn converts 
proinflammatory cytokines IL-1β and IL-18 from inert to active and secreted forms by 
cleavage. The matured cytokines in the extracellular space propagate inflammatory 
responses (Sutterwala et al., 2014; Tschopp & Schroder, 2010).
MWCNT have been reported to induce NLRP3 inflammasome activation in a number of 
studies. In the first report, long needlelike, but not tangled, MWCNT induced secretion of 
IL-1β from LPS (lipopolysaccharides)-primed human primary macrophages, which involved 
NLRP3 inflammasome activation because knocking down of NLRP3 diminished MWCNT-
induced IL-1β secretion (Palomaki et al., 2011). Double-walled CNT (DWCNT) enhanced 
IL-1β release in human monocytes, which was exclusively linked to caspase-1 and NLRP3 
inflammasome activation (Meunier et al., 2012). MWCNT induced IL-1β and IL-18 
secretion in cultured alveolar macrophages isolated from C57BL/6 mice; and increased 
IL-1β secretion was repressed by a caspase-1 inhibitor (Hamilton et al., 2013). MWCNT 
also increased IL-1β secretion in PMA (phorbol myristate acetate)-primed THP-1 human 
monocytes, which was suppressed by caspase-1 inhibitor, and MWCNT treatment led to 
cleavage of pro-caspase-1 to mature caspase-1, indicating the activation of inflammasome 
by MWCNT (Kanno et al., 2014). These studies suggested that NLRP3 inflammasome 
activation contributes to MWCNT-induced inflammation by controlling IL-1β and IL-18 
maturation and secretion.
In addition to the enhanced secretion of IL-1β and IL-18, pyroptosis, another outcome of 
inflammasome activation, was shown to play a role in MWCNT-induced lung injury 
(Hussain et al., 2014). Pyroptosis is a highly inflammatory form of cell death controlled by 
inflammasome-dependent caspase-1 activity (Bergsbaken et al., 2009). MWCNT induced 
pyroptosis in primary human bronchial epithelial (HBE) cells in a time- and dose-dependent 
manner; and induction of pyroptosis was mediated by NLRP3 inflammasome activation, as 
it was significantly reduced by treatment with NLRP3 siRNA (small interfering RNA) or 
caspase-1 inhibitor (Hussain et al., 2014).
It is noteworthy to point out that current studies on NLRP3 inflammasome activation by 
CNT were mostly conducted with MWCNT in cultured cells and the molecular 
understanding of the mechanism by which CNT activate the inflammasome is limited at 
present. Nonetheless, Palomaki et al. (2011) have shown that CNT-induced NLRP3 
inflammasome activation involved ROS production, cathepsin B activity, P2X(7) receptor, 
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and Src and Syk tyrosine kinases, providing molecular targets for further research. In 
addition to CNT, other particles and fibers, including silica, asbestos, alum, and 
nanoparticles, such as nano-TiO2 and nano-SiO2, have been shown to activate the NLRP3 
inflammasome, but their underlying mechanisms and pathologic implications remain 
unaddressed to a large extent (Cassel et al., 2008; Dostert et al., 2008; Hornung et al., 2008; 
Kool et al., 2008; Peeters et al., 2013; Winter et al., 2011; Yazdi et al., 2010). Thus, 
although the research on the CNT-NLRP3 inflammasome interaction is at an early stage, 
detailed analyses on the NLRP3 inflammasome pathway under CNT exposure would 
provide significant new insights into the inflammatory responses triggered by CNT and 
other toxic particles and fibers for future studies.
TGF-β1
The molecular mechanisms underlying lung fibrosis in most animal models and human 
diseases have remained uncertain for the most part, but a number of cytokines, known as 
fibrogenic cytokines because of their capacity to induce or promote fibrosis and/or whose 
expression and function are altered during the development of fibrotic pathology, have been 
identified (Wynn, 2011). Among them, TGF-β1 is considered as a key regulator in fibrosis. 
TGF-β1 induces the recruitment of macrophages and fibroblasts, promotes fibroblast 
proliferation, and stimulates the transformation of fibroblasts to myofibroblasts, which are 
key cellular and molecular events in the development of lung fibrosis (Desmouliere et al., 
1993; Fernandez & Eickelberg, 2012; Sime et al., 1997). TGF-β1 also drives EMT to 
convert epithelial cells to fibroblasts at the site of injury to boost fibrosis (Iwano et al., 2002; 
Kalluri & Neilson, 2003). TGF-β1 binds to its receptors on the surface of target cells to 
initiate the signaling pathway. In the canonical pathway, activated Type 1 receptor 
phosphorylates R-Smads (Smad2 and Smad3), which subsequently form a complex with the 
Co-Smad, Smad4. The resulting active Smad complex enters the nucleus and interacts with 
distinct transcription factors to activate or inhibit the transcription of many TGF-β 
responsive genes involved in apoptosis, cell growth and differentiation, extracellular matrix 
neogenesis, and immunosuppression (Schmierer & Hill, 2007). Additionally, TGF-β1 
activates a number of non-Smad pathways collectively known as the non-canonical 
pathways including PI3K, RAS, PAR6, and JNK/p38/ MAPK pathways, which 
cumulatively regulate TGF-β functions (Chaudhury & Howe, 2009; Zhang, 2009).
Recent studies demonstrated that both SWCNT and MWCNT induced the production of 
TGF-β1 in cultured cells including mouse RAW264.7 macrophages, normal human 
bronchial epithelial cells BEAS-2B, and normal human lung fibroblasts WI38-VA13 (He et 
al., 2011, 2012). In a separate study, long SWCNT increased the expression and secretion of 
TGF-β1 in cultured normal human lung fibroblasts NHLF (Manke et al., 2014). Therefore, 
CNT possess the ability to enhance TGF-β1 expression and function, as shown by in vitro 
studies.
A number of in vivo studies provided evidence to support that TGF-β plays a critical role in 
CNT-induced lung fibrosis. SWCNT-exposed C57BL/6 mice showed EMT and injury in the 
lungs, with an increasing occurrence of epithelium-derived fibroblasts that produced 
collagen, indicating that EMT occurred and contributed to CNT-induced fibroblast 
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expansion; moreover, an elevated number of hyperplastic epithelial cells with positive 
staining for TGF-β/p-Smad2 were observed, suggesting that activation of TGF-β/p-Smad2 
signaling is involved in SWCNT-induced EMT and fibrosis in the lungs (Chang et al., 
2012). Long MWCNT (20–50 µm) increased fibroblast proliferation, collagen deposition, 
and granuloma formation in the lungs of spontaneously hypertensive (SH) rats (Wang et al., 
2013). Furthermore, the long MWCNT induced macrophage activation, TGF-β1 secretion, 
Smad2 phosphorylation, and the expression of collagen III and extracellular matrix (ECM) 
protease inhibitors in vivo; and in vitro studies revealed that the long MWCNT enhanced 
TGF-β1-induced phosphorylation of Smad2 as well as up-regulated the expression of 
collagen III in a TGF-β-dependent manner in mouse embryonic fibroblast NIH3T3 cells. In 
C57BL/6J mice, exposure to long MWCNT (5–15 µm) led to increased collagen deposition, 
pulmonary fibrosis, TGF-β1 secretion and Smad2 phosphoryl-ation (Chen et al., 2014). 
About 20% of the pro-surfactant protein-C positive epithelial cells transformed to fibroblasts 
at 56 d post-exposure, indicating occurrence of EMT. In vitro studies showed that the long 
MWCNT induced TGF-β1 production and Smad2 phosphorylation, down-regulated 
epithelial marker protein E-cadherin, and up-regulated mesenchymal marker protein α-
smooth muscle actin (α-SMA) protein expression in human pulmonary epithelial A549 
cells, which were dependent on TGF-β1 signaling. These studies demonstrated that TGF-β/
Smad signaling is activated by CNT and plays an important role in CNT-induced lung 
fibrosis.
Despite the above findings and the common belief of TGF-β as a promoter of fibrosis, some 
studies demonstrated an opposite role of the TGF-β/Smad pathway in pulmonary pathologic 
responses. For example, blockade of TGF-β/Smad signaling was shown to enhance airway 
inflammation and reactivity (Hansen et al., 2000; Nakao et al., 2000), whereas over-
expression of TGF-β1 in regulatory T cells inhibited bleomycin-induced lung fibrosis 
(Kitani et al., 2003). Thus, TGF-β may have a suppressive effect on tissue remodeling under 
certain conditions. This double-edged nature of TGF-b1 function demands that caution is to 
be taken when analyzing and interpreting studies relating TGF-β to lung fibrosis.
MAPKs
The mitogen-activated protein kinase (MAPK) pathways control a wide range of 
fundamental processes including cell proliferation, differentiation, apoptosis, inflammation, 
and organismal development (Arthur & Ley, 2013; Jeffrey et al., 2007; Munshi & Ramesh, 
2013; Rose et al., 2010; Wagner & Nebreda, 2009). The MAPK pathways are activated in 
response to endogenous signals, such as growth factors, inflammatory cytokines, and 
mitogens, as well as environmental stressors, such as ultraviolet irradiation, oxidants, 
genotoxic agents, and microbial toxins. The MAPK pathways are activated through a well-
conserved three-tiered kinase cascade, in which a MAPK kinase kinase (MAPKKK, 
MAP3K, MEKK, or MKKK) activates a MAPK kinase (MAPKK, MAP2K, MEK, or 
MKK), which in turn activates the MAPK through serial phosphorylation. This kinase 
cascade transduces signals from the cell membrane to the nucleus to regulate a variety of 
intracellular signaling pathways. Well-studied MAPKs include the extracellular signal-
regulated kinase 1 and 2 (ERK1/2), the c-Jun N-terminal kinases 1, 2, 3 (JNK1, 2, 3), the 
p38 MAPKs (p38α, β, γ, δ), and the big MAPK (ERK5). The ERK pathway (ERK1/2) is 
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activated by mitogens and growth factors, and plays a major role in regulating cell growth, 
survival, and differentiation. In contrast, JNK and p38 MAPKs respond most robustly to 
inflammatory cytokines and cellular stresses, and are strongly associated with stress 
responses such as apoptosis and inflammation, although they can also be weakly activated 
by growth factors. ERK5 is activated in response to both growth factors and stresses, and 
has various biological effects on cell growth, survival, and differentiation.
A few studies reported that SWCNT activate MAPK signaling in cultured cells. Significant 
phosphorylation of p38 and ERK1/2 in malignant human mesothelial cells was detected 
upon exposure to SWCNT (Pacurari et al., 2008). In human lung fibroblasts CRL-1490, 
SWCNT induced p38 phosphorylation in a dose-dependent manner, which in turn 
contributed to SWCNT-induced fibrogenesis and angiogenesis through the induction of 
TGF-b1 and vascular endothelial growth factor (VEGF) (Azad et al., 2013). Prolonged 
treatment of human mesothelial cells with SWCNT induced neoplastic-like transformation, 
which was associated with phosphorylation of ERK1/2 (Lohcharoenkal et al., 2014).
MWCNT were shown to induce MAPK activation in several in vitro systems. In a gene 
expression profiling study on human skin fibroblasts, a whole genome expression array 
analysis was performed to identify the genes whose expression was changed at 
transcriptional level upon exposure to MWCNT (Ding et al., 2005). Promoter analysis of the 
microarray results indicated that p38/ERK-MAPK cascades are critical pathways in the 
induced signal transduction by MWCNT. A phosphokinase array study using lysates from 
human bronchial epithelial BEAS-2B cells exposed to MWCNT demonstrated that 
phosphorylation of p38 and ERK1 was significantly increased (Hirano et al., 2010). 
MWCNT increased phosphorylation of ERK1/2 in mouse RAW264.7 macrophages, which 
was critical to the elevated COX-2 expression induced by MWCNT (Lee et al., 2012). In a 
co-culture system in which human small airway epithelial cells (SAEC) and human 
microvascular endothelial cells (HMVEC) were cultured separately by a Transwell 
membrane to mimic an alveolar-capillary interaction, treatment of SAEC with MWCNT 
induced phosphorylation of p38 in HMVEC (Snyder-Talkington et al., 2013).
The above discussed studies on the relation between CNT and MAPK signaling were 
performed in cultured cells and using phosphorylation of MAPKs as the readout of MAPK 
activation, which limit the interpretation of the results. Therefore, detailed in vivo analyses 
are much needed to demonstrate the activation and functional consequences of MAPK 
pathways in CNT-induced toxicity. Analyses of both upstream and downstream components 
in the MAPK cascade under CNT exposure would facilitate to address the mechanisms by 
which CNT modulate the MAPK pathways in future studies.
p53
In addition to stimulating the proliferation of lung cells such as fibroblasts and mesothelial 
cells for their fibrotic and mesothelioma-causing effects, CNT induce cell-cycle arrest, 
apoptosis, and autophagy. For instance, cell-cycle analyses revealed that SWCNT induced a 
G2 block in cell cycle (Sargent et al., 2012; Wang et al., 2011a), whereas exposure to 
MWCNT caused a G1/S block in cultured cells (Han et al., 2012; Siegrist et al., 2014). 
Recent studies showed that SWCNT induced apoptosis in rat pheochromocytoma PC12 cells 
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and rat aorta endothelial cells (Cheng et al., 2011; Wang et al., 2011a), and MWCNT 
stimulated apoptosis in rat glioma cells and RAW 264.7 cell-derived osteoclasts (Han et al., 
2012; Ye et al., 2012). In addition, SWCNT were shown to stimulate autophagy in 
BEAS-2B cells, with up-regulated autophagy-related genes and autophagosome formation-
related proteins (Park et al., 2014), and certain types of MWCNT affect autophagy, as 
examined in a fluorescent autophagy-reporting cell line (Wu et al., 2014).
The tumor suppressor protein p53 plays a critical role in the control of cell proliferation and 
cell death, two fundamental biological functions critical in many physiological, 
developmental, and disease processes during organismal life, by directly regulating cell 
cycle, apoptosis, and the response to genomic damage. Given the dominant role of p53 in 
the regulation of cell proliferation and cell death, it is rational to posit that the tumor 
suppressor protein is involved in CNT-induced toxicity, which has been supported by some 
experimental evidence. SWCNT were shown to affect cell proliferation and apoptosis by 
interrupting p53 signaling in cultured cells. Prolonged (6 months) exposure to SWCNT 
caused malignant transformation of human lung epithelial BEAS-2B cells showing 
characteristics of cancer stem cells, such as excessive cell growth and colony formation. The 
transformed cells were resistant to apoptosis and induced tumors in nude mice. These cells 
had decreased phosphorylation of p53, a major determinant of p53 function. This study 
indicated that prolonged exposure to SWCNT perturbs p53 signaling, leading to loss of 
function of p53, promotion of cell proliferation, and inhibition of apoptosis (Wang et al., 
2011b). A follow-up study confirmed that, in cells transformed by prolonged exposure to 
SWCNT, the total p53 protein level was dramatically decreased, which involved the plasma 
membrane-associated protein caveolin-1 (Cav-1), supporting a role of p53 and Cav-1 in 
CNT tumorigenesis (Luanpitpong et al., 2014).
In the initial study with heterozygous p53+/− mice, decreased function of p53 was shown to 
promote induction of mesotheliomas in the peritoneal cavity injected with MWCNT at a 
dose of 3 mg per mouse (Takagi et al., 2008). In a follow-up study, a dose-response curve at 
much lower doses was pursued in p53+/− mice with MWCNT (3, 30, or 300µg/mouse, 
intraperitoneal injection, 1 year); mesotheliomas were observed at all doses with a dose-
dependent cumulative incidence, further supporting that MWCNT induce mesotheliomas, in 
a p53 compromised genetic background (Takagi et al., 2012). In a recent study, intravenous 
injection of large-sized MWCNT into pregnant p53 heterozygous mice induced p53-
dependent responses during fetal development, manifesting restriction of fetal development 
and deformity of the brain; moreover, molecular analyses revealed that the MWCNT 
triggered p53-dependent apoptosis and cell-cycle arrest in response to MWCNT-induced 
DNA damage; but SWCNT and small-sized MWCNT failed to induce fetotoxicity. This 
study demonstrates that p53 modulates MWCNT fetotoxicity by controlling cell 
proliferation and cell death (Huang et al., 2014).
A working model for CNT pathogenic effects
The study on CNT has served as a model for analyzing nanotoxicity. The major findings 
conclude that CNT can induce a variety of adverse effects in experimental systems including 
cytotoxicity, inflammation, fibrosis, genotoxicity, tumorigenesis, and immune effects, which 
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extend well beyond the predictions from “nuisance dust”-like fibers (Figure 2). As a result, 
the health impacts of CNT on humans have evolved into an urgent issue to evaluate, discuss, 
and prevent. Under such a situation, a comprehensive understanding of the characteristics of 
pathogenic CNT and the cellular and molecular mechanisms underlying CNT-triggered and 
disease-related effects is imminently required. In this review, we provide a summary and a 
discussion of the current advances in these areas, which allow us to propose a working 
model to integrate determinants of CNT toxic activities, molecular mechanisms, and 
signaling pathways relating to the development of inflammation, fibrosis, and tumorigenesis, 
three major pathogenic effects observed in animals exposed to CNT (Figure 4).
Respirable CNT fibers exhibit apparent pathogenic potentials to induce toxicity and diseases 
similar to those by asbestos fibers. CNT also show dynamic and specific behaviors in their 
deposition, distribution, and clearance in tissue compartments in the body. Moreover, many 
toxic effects of CNT depend on their physicochemical properties, in particular, their 
solubility, bioper-sistence, rigidity, physical state, fiber length, surface area, and surface 
reactivity, which determine CNT’s intrinsic pathogenicity, in vivo kinetics, and internal 
dose. The molecular mechanisms by which pathogenic fibers and particles, including CNT, 
asbestos, and silica, cause toxicity have remained poorly understood for the most part; but a 
few molecular events have been observed in animal and cell models exposed to CNT, 
among which, oxidative stress, inflammation, proliferative response, fibroblast proliferation 
and differentiation, oxidative DNA base damage and clastogenic/aneugenic abnormalities, 
as well as immuno-modulatory effects, have been demonstrated to provide a mechanistic 
explanation to CNT toxicity at molecular level. Mechanistic studies have also uncovered a 
number of cellular signaling pathways; in particular, the NF-κB, NLRP3 inflammasome, 
TGF-β1, MAPK, and p53 pathways have been recognized to play important roles in CNT-
induced pathologic phenotypes. More specifically, the NF-κB, NLRP3 inflammasome and 
MAPK signaling may be involved in inflammatory responses, whereas the NF-κB, TGF-β1, 
MAPK, and p53 signaling may contribute to fibrosis and tumorigenesis, following CNT 
exposure.
The findings on CNT toxicity have created a body of knowledge critical for understanding 
the health effects of nanoexposure, as well as for providing guidance to risk assessment, 
screening of new nanomaterials, policy making, and prevention-through-design for 
nanoapplications. These efforts have significantly impacted on and will continue to promote 
the safe and responsible development of the nanoindustry; and, at the same time, protect 
humans and the environment from potentially deleterious effects of nanomaterials and 
products.
Perspectives
Issues relating to nanotoxicity
It is evident that the research on CNT toxicity is still at its early but rapidly growing stage, 
and a number of major knowledge gaps relating to CNT’s structure–toxicity relationship and 
molecular mechanisms of action remain to be filled.
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One challenging issue derives from the fact that, despite of large efforts, the properties of 
CNT at the nanoscale, which define their relevance to nanotechnology, have not been 
convincingly linked to the biological activities of CNT. For instance, CNT have been 
hypothesized to perturb the structure and functions of the mitotic spindle in the nucleus, 
which may explain their clastogenic effects. Similarly, CNT in the extracellular matrix are 
thought to attract and activate fibroblasts in the interstitial space of the lungs by mimicking 
collagen fibers, because of their nanoscale size and fiber-like shape. Conceivably, detailed 
molecular analyses of the interactions between CNT and the subcellular and molecular 
targets would be required to identify “nanotube-specific” toxic effects and the mechanisms 
of action underlying the effects.
From a mechanistic point of view, only a small number of cellular mechanisms and 
signaling pathways critical to disease occurrence and development have been detected and 
reported under CNT exposure. Even for the relatively well-studied mechanisms and 
signaling pathways as summarized above, the molecular details and biological consequences 
are lacking in these cases. For instance, most of the mechanistic studies have been 
performed in cultured cells, thus lacking the in vivo confirmatory information; many of the 
findings are based on the observation of positive readout of a specific signaling molecule or 
pathway, missing the necessary characterization of critical upstream and downstream 
components involved in the signal cascade, such as the initial events responsible for the 
activation of a specific pathway by CNT; and the detailed pathological functions of a certain 
pathway in the onset of disease-related phenotypes induced by CNT have not been 
addressed to a large extent. In contrast, these issues are largely anticipated to encounter, 
given that the mechanistic study of nanotoxicity is at its early stage and the molecular 
mechanisms of toxicity for fibers and particles including asbestosis and silicosis have 
remained poorly understood for the most part. Future research into these issues would 
promise to provide significant new insights into the toxicity and safety of pathogenic fibers 
and particles, including CNT and their products.
The observations that toxicity can be reduced by changing CNT’s surface reactivity, i.e. 
functionalization and coating, pointed out new ways to build safety into the design of 
nanoproducts, but the research in this area remains elementary. Further analyses of how 
modification of CNT surface alters CNT behavior and toxicity in vivo at cellular and 
molecular levels would yield valuable new insights into CNT biology and nanotoxicology.
Because there appears to be a lack of CNT-specific toxicity, and most of the identified toxic 
effects, mechanisms of action, and signaling pathways of toxic CNT can be found from 
exposure to non-nanomaterials, such as asbestos and silica, it was proposed that CNT may 
be grouped either as high toxicity fibers, which often represent rigid, biopersistent, and 
respirable fibers with a specific geometry and high aspect ratio, or low toxicity fibers, which 
typically reflect insoluble, granular, and biodurable particles and fibers. This categorization 
assumes that CNT can be distinguished by their dose response curves of toxicity, although 
they may share similar mode of action and signaling pathways, if a sufficiently high dose is 
given. Additionally, a third category was proposed for nanomaterials whose toxicity is 
mediated by specific chemical properties of their components and thus, should be evaluated 
individually (Gebel et al., 2014). It is conceivable that further mechanistic understanding of 
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the differences in the toxicity and mechanisms of action between high and low toxicity CNT 
would be needed before this classification of CNT becomes meaningful for practical use.
Issues relating to new developments in nanotechnology
Nanotechnology has been advancing rapidly and will keep this rapid pace of innovation in a 
foreseeable future, continuously introducing novel and “smart” nanomaterials of newer 
generations, whose health effects would be uncertain and require toxicological evaluations. 
In recent years, a number of new nanomaterials or nanoscale materials have been created 
and used for industrial and commercial applications, raising considerable new challenges for 
toxicological evaluation of the materials, which would require new methodology and 
mechanistic insights with regard to their potential health effects.
In the first example, CNT have been exploited to produce nanomedicine for therapeutic and 
diagnostic purposes, owing to their unique physicochemical properties. For instance, drugs 
can be linked to CNT through covalent or noncovalent attachment on the surface of CNT, or 
can be filled within the tubular structure of CNT, for delivery. As CNT have the ability to 
cross the various biological barriers in the body and penetrate into the cell, they have the 
potential to efficiently and directly deliver drugs to target cells and tissues. Therefore, CNT 
have become good candidates as drug carriers recently. As examples, the breast cancer drug 
Paclitaxel linked to SWCNT and the human gastric carcinoma drug HCPT linked to 
MWCNT have been tested in vitro and in mice (Liu et al., 2008; Wu et al., 2009).
The potential applications of CNT to therapeutic platforms demand imperative toxicological 
considerations and evaluations of CNT-based drugs, due to the identified cytotoxic and 
pathologic effects induced by CNT. After the drug is released from CNT, the CNT vehicles 
may continue to deposit and accumulate in targeted cells and tissues, and thus may result in 
local toxic effects. CNT released at the targeted site may also enter the circulation and 
translocate to distant organs, such as the cardiovascular system and lymph nodes, leading to 
systemic effects. Therefore, CNT-based medicines will need to be evaluated for the in vivo 
distribution, pharmaco- and toxicokinetics, and internal dose of the CNT vehicles, for the 
purpose of developing physiologically safe and therapeutically effective nanomedicine in 
humans.
“Active nanomaterials” and “nanoscale sophisticated materials” are two examples of novel 
nanomaterials. An “active” nanomaterial is a nanostructure that changes or evolves its state 
during its operation, as defined according to the National Science Foundation in the Active 
Nanostructures and Nanosystems grant solicitation in 2006. Five types of active 
nanomaterials have emerged, including (a) remote actuated active nanostructure; (b) 
environmentally responsive active nanostructure; (c) miniaturized active nanostructure; (d) 
hybrid active nanostructure; and (e) transforming active nanostructure (Subramanian et al., 
2010). A few examples that involve active nanostructures are nanoelec-tromechanical 
systems, targeted drugs and chemicals, sensors, self-healing materials, and energy storage 
devices. Unlike traditional or passive nanomaterials, active nanomaterials can shift from a 
passive stage to an active stage, which may render them extra activity and functions 
including potential and previously uncharacterized toxic effects.
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The “nanoscale sophisticated” materials possess novel, dynamic, multifaceted, and even 
time- and context-specific functionality. Based on the definition, the materials that (a) 
demonstrate abrupt scale-specific changes in biological or environmental behavior, (b) are 
capable of penetrating to normally inaccessible places, (c) are active, (d) are self-
assembling, or (e) exhibit scalable hazard that is not captured by conventional hazard 
assessments, have been classified as sophisticated materials, which were introduced and 
reviewed elaborately by Maynard et al., (2011). Accordingly, the nanoscale sophisticated 
materials may have more complicated physicochemical properties, in vivo kinetics, and 
bioactivities, compared with traditional nanomaterials.
The production and applications of these active nanomaterials and nanoscale sophisticated 
materials demand careful consideration and evaluation with regard to the health risks that 
these new materials might pose, bringing about new challenges in toxicology studies. 
Conceivably, the research methods that have been developed and the findings that have been 
achieved on the toxicity of CNT and other traditional nanomaterials are expected to be 
applicable to the health effect studies on these new materials, which, together with new 
tools, experimental designs, and methodologies to be established and commensurate with the 
novel and complex features and functions of the new materials, would allow the study into 
critical toxicological issues, such as how the physicochemical properties and chemical 
composition of active nanomaterials and sophisticated materials interact with cells and bio-
molecules to determine their dynamic behaviors, molecular interactions, and ultimately, 
toxicity within a biological system.
Conclusions
The expanding production and applications of CNT-related materials could result in an 
unavoidable and increasing human exposure to CNT, which has developed into an 
environmental and occupational issue in the toxicology field, due to the identified effects 
induced by CNT. Understanding the molecular mechanisms related to CNT-induced toxicity 
and pathology is a necessary approach to elucidate and prevent the adverse effects of using 
CNT as new materials in human life. In addition, results from the research on CNT toxicity 
will provide new clues for developing, producing and applying novel nanomaterials that will 
be hazardless to humans and to the environment. We anticipate an intensive research effort 
and a bloom of new findings in the field of nanotoxicology during the coming few years.
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8-OHdG 8-hydroxydeoxyquanosine
α-SMA α-smooth muscle actin
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ALD atonic layer deposition
ASC apoptosis-associated speck-like protein containing a caspase 
activation and recruitment domain








EGF epidermal growth factor
ELISA enzyme-linked immunosorbent assay
EMT epithelial-mesenchymal transition
ERK extracellular signal-regulated kinase
GFR growth factor receptor
IFN interferon
IgE immunoglobulin E
IKKα IκB kinase α
IL interleukin
IL1R interleukin-1 receptor
iNOS inducible nitric oxide synthase
JNK c-Jun N-terminal kinase
LPS lipopolysaccharides
MAPK mitogen-activated protein kinase
MAPKK MAPK kinase
MAPKKK MAPK kinase kinase
MCA methylcholanthrene
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NADPH nicotinamide adenine dinucleotide phosphate
NF-κB nuclear factor-κB
NK natural killer
NLR nucleotide-binding oligomerization domain-like receptor
NLRC4 nucleotide-binding oligomerization domain-like receptor: caspase 
activation and recruitment domain-containing 4





PAR6 partitioning defective protein 6
PDGF platelet-derived growth factor
PDTC pyrrolidine dithiocarbamate
PI3K phosphoinositide 3-kinase
PMA phorbol myristate acetate
RAS retrovirus-associated DNA sequences
RNS reactive nitrogen species
ROS reactive oxygen species
SAEC small airway epithelial cells
siRNA small interfering RNA
Smad contraction of Sma and Mad (mothers against decapentaplegic)
SWCNT single-walled CNT
TGF transforming growth factor
Th2 T helper 2
TLR toll-like receptor
TNF tumor necrosis factor
TNFR tumor necrosis factor receptor
TPCK N-tosyl-l-phenylalanine chloromethyl ketone
VEGF vascular endothelial growth factor
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Human exposure to carbon nanotubes. The major source of CNT is industrial 
manufacturing, owing to a diversity of CNT applications. The production activity leads to a 
direct occupational exposure to humans, a release of CNT to natural environment, and 
potentially an accumulation of CNT in food web as CNT are resistant to degradation 
mechanisms. Humans can be exposed to CNT through inhalation, skin absorption, ingestion, 
or the use of CNT-carried drugs.
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Toxicological and pathological effects of carbon nanotubes. A variety of CNT-induced 
effects have been identified in recent studies performed in cultured mammalian cells and 
experimental animals. These effects demonstrate the potential health impacts of CNT 
exposure on humans.
Dong and Ma Page 40














Signaling molecules and pathways activated by carbon nanotubes. It has been demonstrated 
that CNT can positively or negatively influence several signaling cascades that play critical 
roles in physiological and pathological conditions, including the NF-κB, NLRP3 
inflammasome, p53, TGF-β1, and MAPK pathways. Dysregulation of these pathways leads 
to abnormal gene expression and protein function, and eventually results in disease 
occurrence and progression.
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A working model for molecular mechanisms underlying CNT-induced diseases. The 
activation of NF-κB and NLRP3 inflammasome plays important functions in the 
inflammatory responses induced by CNT. TGF-β1 signaling triggers EMT and fibroblast to 
myofibroblast transformation, and results in fibrosis under CNT exposure. Abnormal p53 
function plays a critical role in CNT-induced tumorigenesis, through dysregulating cell 
proliferation and apoptosis. Although in vivo studies have not been performed, NF-κB, p53, 
and/or MAPK pathways may contribute to the onset of fibrosis, and NF-κB, TGF-β1, and/or 
MAPK activation is expected to be involved in tumorigenesis following CNT exposure, 
according to the functions of these pathways. Meanwhile, as a critical and rapid-onset 
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immune response, inflammation may initiate and facilitate both fibrosis and tumorigenesis 
following exposure to CNT.
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